3 Comments
User's avatar
⭠ Return to thread
Robert Berkowitz, MD's avatar

Maybe you are pointing to another reason besides being “flush with cash” that Pfizer just purchased Global Blood Therapeutics (GBT.O), the company that makes the drug Oxbryta, a novel treatment for Sickle Cell Disease. Is Pfizer anticipating the need to focus efforts on managing the impact of its vaccine-induced hemoglobin misfolding?

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-buy-global-blood-therapeutics-54-bln-deal-2022-08-08/

Expand full comment
Charliecj's avatar

Can you imagine telling the Worlds population that they all must now take “our new post vaccine” drug! And it’s only $900 a pop!

Expand full comment
YYR's avatar

Yes.

Expand full comment